openPR Logo
Press release

Fanconi’s Anemia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results | Elixirgen Scientific, Abeona Therapeutics

04-15-2019 12:39 PM CET | Health & Medicine

Press release from: Fanconi’s Anemia Therapeutics-Pharma Proff

Fanconi’s Anemia Therapeutics- Pipeline Analysis 2018,

Fanconi anemia is an inherited disease, caused by mutations in FA genes. These genes provide instructions to repair certain types of DNA damage in the human body. The cells of healthy people often repair DNA damage; however, cells affected by Fanconi anemia are not able to repair damages.

Download the sample report at: https://www.pharmaproff.com/request-sample/1038

The symptoms associated with the disease are decreased blood cell counts, bone problems, vitiligo, deafness, eye problems, short height, small head, small testicles and genital changes. The disease can be diagnosed by bone marrow biopsy, complete blood count test, hearing test, computed tomography (CT) scan and magnetic resonance imaging (MRI).

Get the detailed analysis at: https://www.pharmaproff.com/report/fanconis-anemia-therapeutics-pipeline-analysis

The disease can be treated by growth factors, hormone therapy, antibiotics and blood transfusions. According to the data published by the National Organization for Rare Disorders, the incidence rate of Fanconi anemia is estimated to be around 1 in 136,000 births.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1038

This condition is more common among people of Ashkenazi Jewish descent, the Roma population of Spain, and black South Africans. Some of the major companies having therapeutic agents for the treatment of Fanconi's anemia in their pipeline include Elixirgen Therapeutics LLC, Abeona Therapeutics, Inc. and others. For instance, Abeona Therapeutics Inc. is in the process of developing ABO-301 gene therapy for the treatment of Fanconi anemia.

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fanconi’s Anemia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results | Elixirgen Scientific, Abeona Therapeutics here

News-ID: 1703153 • Views: 1100

More Releases for Fanconi

Cystinosis Treatment Market Scrutinized in New Research 2018-2026 With Key Compa …
Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the pancreas, muscles, testes, and thyroid can also be affected. Cystinosis is categorized into three different types; nephropathic, non-nephropathic or ocular, and intermediate cystinosis. Nephropathic (infantile) cystinosis is the most
Fanconi Anemia Drug Market Strategy and Growth Factor Report 2019| Top Key Playe …
Fanconi Anemia Drug Market Summary Reports Monitor included a new market research study on Size, Status, and Forecast Market with several graphs, pie charts, tables, and figures, which makes it easier for the users to comprehend the report. Currently, the market is expanding its presence. Download Research Study With Latest Advancement Trends and Application @ https://www.reportsmonitor.com/request_sample/300628 The report includes an in-depth analysis of the industrial value chain, which provides a detailed view of the Fanconi
Cystinosis Treatment Market - Global Industry Insights, Trends, 2026
Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the pancreas, muscles, testes, and thyroid can also be affected. Cystinosis is categorized into three different types; nephropathic, non-nephropathic or ocular, and intermediate cystinosis. Nephropathic (infantile) cystinosis is the most
Global Fanconi Anemia Drug Market 2018 - Abeona Therapeutics Inc, Genethon SA
Apex Market Reports, recently published a detailed market research study focused on the “Fanconi Anemia Drug Market” across the global, regional and country level. The report provides 360° analysis of “Fanconi Anemia Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Fanconi
Global Fanconi Anemia Drug Sales Market Volume, Revenue, Product Price, Top Play …
"The Report Global Fanconi Anemia Drug Sales Market Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Fanconi Anemia Drug Sales Market In this report, the global Fanconi Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Global Fanconi Anemia Drug Market Usage, Dosage, Side-Effect, Analysis, Treatmen …
To understand the medium infrared heaters Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Global Fanconi Anemia Drug Sales Market Report 2017” to its vast database. In the recent times, the fanconi anemia drug sales market has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendor’s fanconi anemia